Table 1 Baseline patient characteristics.
N = 503 | |
|---|---|
Age, year, mean (SD) | 68.2 ( 9.1) |
Gender (male), n (%) | 478 (76.5%) |
BMI, kg/m2, n (%) | 28.1 ± 4.9 |
Current smoker, n (%) | 100 (19.9%) |
COPD, n (%) | 40 (8.0%) |
Hypertension, n (%) | 370 (73.6%) |
Dyslipidaemia, n (%) | 354 (70.4%) |
Medically treated diabetes, n (%) | 150 (31.6%) |
Insulin use, n (%) | 51 (10.1%) |
Previous MI, n (%) | 28 (5.6%) |
History of PVD, n (%) | 34 (6.8%) |
Previous stroke, n (%) | 26 (5.2%) |
History of heart failure, n (%) | 82 (16.3%) |
Acute coronary syndrome, n (%) | 201 (41.4%) |
Chronic coronary syndrome, n (%) | 285 (58.6%) |
Systolic blood pressure, mmHg, mean (SD) | 136.7 ± 21.2 |
Diastolic blood pressure, mmHg, mean (SD) | 76.6 ± 12.0 |
Heart rate, /min, mean (SD) | 70.9 ± 13.4 |
LVEF, %, mean (SD) | 54.3 ± 10.4 |
Creatinine clearance, mg/dl, mean (SD) | 1.08 ± 0.88 |
Site SYNTAX score, mean (SD) | 18.8 ± 8.0 |
Core lab SYNTAX score, mean (SD) | 22.1 ± 8.3 |
Statin, n (%) | 386 (76.7%) |
ACEI, n (%) | 216 (42.9%) |
ARB, n (%) | 129 (25.6%) |
Beta-blocker, n (%) | 306 (60.8%) |
Calcium channel blocker, n (%) | 166 (33.0%) |
Diuretics, n (%) | 135 (26.8%) |
Anticoagulation, n (%) | 46 (9.1%) |
